Endothelin receptor antagonists for pulmonary arterial hypertension
Pulmonary arterial hypertension (PAH) is a consequence of acute or chronic disorder of the pulmonary vasculature, which is characterized by increased pulmonary artery pressure as a result of increased pulmonary vascular resistance. The pathophysiology of PAH is characterized by pulmonary vascular va...
Guardado en:
Autores principales: | Bevacqua, R.J., Bortman, G., Perrone, S.V. |
---|---|
Formato: | JOUR |
Materias: | |
Acceso en línea: | http://hdl.handle.net/20.500.12110/paper_18501044_v8_n2_p77_Bevacqua |
Aporte de: |
Ejemplares similares
-
Endothelin receptor antagonists for pulmonary arterial hypertension
Publicado: (2013) -
Future advances in pulmonary arterial hypertension
por: Bevacqua, R.J., et al. -
Future advances in pulmonary arterial hypertension
Publicado: (2013) -
Pulmonary arterial hypertension /
Publicado: (2012) -
Plasmatic biochemical variables associated with polymorphisms in the endothelin-1 and endothelin-1 receptor a genes in hypertensive patients : pilot study
por: Lassen, Oscar, et al.
Publicado: (2022)